Literature DB >> 28661033

Engineered Heart Repair.

B Fujita1,2,3, W-H Zimmermann1,2.   

Abstract

There is a pressing need for the development of advanced heart failure therapeutics. Current state-of-the-art is protection from neurohumoral overstimulation, which fails to address the underlying cause of heart failure, namely loss of cardiomyocytes. Implantation of stem cell-derived cardiomyocytes via tissue-engineered myocardium is being advanced to realize the remuscularization of the failing heart. Here, we discuss pharmacological challenges pertaining to the clinical translation of tissue-engineered heart repair with a focus on engineered heart muscle (EHM).
© 2017 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28661033      PMCID: PMC5657241          DOI: 10.1002/cpt.724

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Parthenogenetic stem cells for tissue-engineered heart repair.

Authors:  Michael Didié; Peter Christalla; Michael Rubart; Vijayakumar Muppala; Stephan Döker; Bernhard Unsöld; Ali El-Armouche; Thomas Rau; Thomas Eschenhagen; Alexander P Schwoerer; Heimo Ehmke; Udo Schumacher; Sigrid Fuchs; Claudia Lange; Alexander Becker; Wen Tao; John A Scherschel; Mark H Soonpaa; Tao Yang; Qiong Lin; Martin Zenke; Dong-Wook Han; Hans R Schöler; Cornelia Rudolph; Doris Steinemann; Brigitte Schlegelberger; Steve Kattman; Alec Witty; Gordon Keller; Loren J Field; Wolfram-Hubertus Zimmermann
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

2.  Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.

Authors:  Johannes Riegler; Malte Tiburcy; Antje Ebert; Evangeline Tzatzalos; Uwe Raaz; Oscar J Abilez; Qi Shen; Nigel G Kooreman; Evgenios Neofytou; Vincent C Chen; Mouer Wang; Tim Meyer; Philip S Tsao; Andrew J Connolly; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Circ Res       Date:  2015-08-19       Impact factor: 17.367

3.  Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

Authors:  Malte Tiburcy; James E Hudson; Paul Balfanz; Susanne Schlick; Tim Meyer; Mei-Ling Chang Liao; Elif Levent; Farah Raad; Sebastian Zeidler; Edgar Wingender; Johannes Riegler; Mouer Wang; Joseph D Gold; Izhak Kehat; Erich Wettwer; Ursula Ravens; Pieterjan Dierickx; Linda W van Laake; Marie Jose Goumans; Sara Khadjeh; Karl Toischer; Gerd Hasenfuss; Larry A Couture; Andreas Unger; Wolfgang A Linke; Toshiyuki Araki; Benjamin Neel; Gordon Keller; Lior Gepstein; Joseph C Wu; Wolfram-Hubertus Zimmermann
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

4.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.

Authors:  Wolfram-Hubertus Zimmermann; Ivan Melnychenko; Gerald Wasmeier; Michael Didié; Hiroshi Naito; Uwe Nixdorff; Andreas Hess; Lubos Budinsky; Kay Brune; Bjela Michaelis; Stefan Dhein; Alexander Schwoerer; Heimo Ehmke; Thomas Eschenhagen
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

Review 5.  Distilling complexity to advance cardiac tissue engineering.

Authors:  Brenda M Ogle; Nenad Bursac; Ibrahim Domian; Ngan F Huang; Philippe Menasché; Charles E Murry; Beth Pruitt; Milica Radisic; Joseph C Wu; Sean M Wu; Jianyi Zhang; Wolfram-Hubertus Zimmermann; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2016-06-08       Impact factor: 17.956

  5 in total
  3 in total

1.  Process Improvement for Maximized Therapeutic Innovation Outcome.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2018-01       Impact factor: 6.875

2.  Health Care Evolves From Reactive to Proactive.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Pharmacol Ther       Date:  2019-01       Impact factor: 6.875

3.  Characteristics and toxicity assessment of electrospun gelatin/PCL nanofibrous scaffold loaded with graphene in vitro and in vivo.

Authors:  Xi Chen; Bei Feng; Di-Qi Zhu; Yi-Wei Chen; Wei Ji; Tian-Ji Ji; Fen Li
Journal:  Int J Nanomedicine       Date:  2019-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.